First pediatric heart transplantation from a pediatric donor heart in Japan

Circulation Journal

Volumn 76, Issue 3, 2012, Pages 752-754

  Ueno, Takayoshi ^a   Fukushima, Norihide ^a   Sakaguchi, Taichi ^a   Ide, Haruki ^a   Ozawa, Hideto ^a   Saito, Shunsuke ^a   Ichikawa, Hajime ^b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Cardiomyopathy; Pediatrics; Transplantation

Indexed keywords

BASILIXIMAB; CREATININE; CYCLOSPORIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

ARTICLE; ASSISTED VENTILATION; CASE REPORT; CONTINUOUS HEMODIAFILTRATION; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; HEART LEFT VENTRICLE FAILURE; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; JAPAN; LOW DRUG DOSE; MALE; NEPHROTOXICITY; ORGAN DONOR; PEDIATRICS; POSTOPERATIVE PERIOD; RESTRICTIVE CARDIOMYOPATHY; UREA NITROGEN BLOOD LEVEL; WEIGHT GAIN;

ADOLESCENT; CARDIOMYOPATHY, RESTRICTIVE; CHILD; GOVERNMENT REGULATION; HEART TRANSPLANTATION; HUMANS; JAPAN; MALE; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; TREATMENT OUTCOME;

EID: 84857599363     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-1001     Document Type: Article

References (9)

1. Saito S, Matsumiya G, Sakaguchi T, Miyagawa S, Yoshikawa Y, Yamauchi T, et al. Risk factor analysis of long-term support with left ventricular assist system. Circ J 2010; 74: 715-722.
2. Kinugawa K. How to treat stage D heart failure? When to implant left ventricular assist devices in the era of continuous flow pumps? Circ J 2010; 74: 233-239.
3. Kirk R, Edwards LB, Kucheryavaya AY, Aurora P, Christie JD, Dobbels F, et al. Registry of the international society for heart and lung transplantation: Thirteenth official pediatric heart transplantation report 2010. J Heart Lung Transplant 2010; 29: 1119-1128.
4. Singh TP, Edwards LB, Kirk R, Boucek MM. Era effect on post-transplant survival adjusted for baseline risk factors in pediatric heart transplant recipients. J Heart Lung Transplant 2009; 28: 1285-1291.
5. Irving CA, Kirk R, Parry G, Hamilton L, Dark JH, Wrightson N, et al. Outcomes following more than two decades of paediatric cardiac transplantation. Eur J Cardiothorac Surg 2011; 40: 1197-1202.
6. Hertz MI, Aurora P, Boucek MM, Christie JD, Dobbels F, Edwards LB, et al. Registry of the International Society for Heart and Lung Transplantation: Introduction to the 2007 annual reports-100,000 transplants and going strong. J Heart Lung Transplant 2007; 26: 763-768.
7. Tönshoff B, Höcker B. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity. Pediatr Transplant 2006; 10: 721-729.
8. Shlipak M, Massie B. The clinical challenge of cardiorenal syndrome. Circulation 2004; 110: 1514-1517.
9. Groetzner J, Kaczmarek I, Schulz U, Stegemann E, Kaiser K, Wittwer T, et al; VENINAHTx-Investigator. Mycophenolate and sirolimus as calcineurin inhibitor-free immunosuppression improves renal function better than calcineurin inhibitor-reduction in late cardiac transplant recipients with chronic renal failure. Transplantation 2009; 87: 726-733.